Canlubo, Wyeth P.

HRN: 16-77-53  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2025
AMPICILLIN 1GM (VIAL)
07/18/2025
07/20/2025
IVTT
2g
Q6h
PROM X7hours
Checking Initial Appropriateness 
07/19/2025
CEFUROXIME 1.5GM (VIAL)
07/19/2025
07/21/2025
IV
1.5g
Q8hrs
S/P LSTCS
Waiting Final Action 
07/19/2025
CEFUROXIME 500MG (TAB)
07/21/2025
07/28/2025
ORAL
500mg
BID
S/P LSTCS
Waiting Final Action 
07/19/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/19/2025
07/26/2025
IV
500mg
Q8hrs
S/P LSTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: